spacer
home > epc > spring 2009 > the laws of attraction
PUBLICATIONS
European Pharmaceutical Contractor

The Laws of Attraction

The most challenging bottleneck for nearly every clinical trial is the recruitment of the intended number of patients within the planned timeframe. The selection of the best study sites is therefore of crucial importance to the success of a clinical trial. In order to find a suitable site, it is necessary to understand the motivation to participate. These motivations can include:

  • Scientific interest in a new therapy option: this is a very frequent reason to participate in clinical trials, especially for university hospitals and other scientific oriented organisations
  • The possibility to offer clinical studies to the patients: centres for specific indications and severe diseases are expected to be able to provide the option to participate in clinical trials to their patients
  • Strong relation to the sponsor: if an investigator has already been involved in early stages of the clinical development, they are certainly likely to be interested in participating in later phase clinical studies
  • Financial interests: especially for clinical studies with substances that are not in the frontline of scientific interest, the fee for the treatment of patients within a study may be a motivator for participation in a clinical trial

Good sites combine as many of the above-mentioned motivations as possible.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer

Michael Sigmund is Managing Director of SSS International Clinical Research, which provides CRO services to the pharmaceutical and biotech industry. Michael has about 20 years’ experience in the field of clinical research. After studying veterinary medicine, he received his DVM in 1988 from the University of Munich. He then joined the pharmaceutical industry and held several positions within biotech and contract research companies. Michael has ample experience in setting up and running clinical trials in European countries. His main interest lies in steamlining information concerning clinical trials to allow easy and effective access to relevant status information for all  parties involved. Michael helped to develop SSS’s professional web-based study information system (SIS).

spacer
Michael Sigmund
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

BioPartnering North America™

26-28 February 2012, Vancouver Convention Centre, Vancouver, BC, Canada

BioPartnering North America 2012 (BPN) in Vancouver, Canada brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
More info >>

 
News and Press Releases

Topa Thermal Packaging introduces innovative pallet shipper

Topa Thermal Packaging has developed an innovative packaging for manufacturers that transport large quantities of temperature-sensitive products by road and air transport, such as vaccines and medicines. The ‘ClimateBox™ half PAG Pallet Shipper’ delivers significant time and cost savings, thanks to an efficient filling system.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.